Sunday, December 23, 2012
Friday, November 16, 2012
Wednesday, October 24, 2012
Key factors impacting on the mental health and well-being of refugees and asylum seekers in the resettlement context. - Luke Fullagar
Wednesday, October 17, 2012
Early Monitoring of Prodromal Symptoms in Bipolar Disorder
Early Monitoring of Prodromal Symptoms in Bipolar Disorder
Luke Fullagar
RMIT University
Early monitoring of prodromal symptoms has been included in numerous efficacious adjunctive psychosocial approaches to the treatment of bipolar disorders (e.g. Family Focused Treatment (FFT) (Simoneau et al., 1999); Cognitive Behavioural Therapy (CBT) (Lam et al., 2000) (in both one-on-one (Lam et al., 2000; 2003; 2005) and group settings (Castle et al., 1997)); Interpersonal and Social Rhythm Therapy (IPSRT) (Frank et al., 1999); and Psychoeducation (Colom et al., 2003).
Prodromal symptoms emerge during the time between when symptoms are first recognised and when they reach an apex of severity (Molinar et al., 1988). Because bipolar disorders involve a characteristic fluctuation in mood, behavior, and cognition, detecting and managing these symptoms during the early prodromal phase is critical and has been shown to assist in both preventing and reducing the severity of bipolar episodes (Joyce, 1985; Perry et al., 1999). Moreover, psychosocial interventions that include early symptom monitoring have also been shown to positively assist in: relapse prevention, increasing time to relapse, decreasing rate of hospitalisation, lowering symptom severity and episode length, and enhancing quality of life (Gitlin et al., 1995; Lam et al., 2003; Morriss et al., 2002; Scott et al., 2001).
Patients with chronic conditions including bipolar disorders report a need for both self-help and psychosocial treatments in conjunction with pharmacotherapy (Hill, Hardy & Shepard, 1996; Lish et al., 1994), in which they are an active partner in the management of their condition. Psychosocial interventions that include early monitoring of prodromal symptoms meet this need by assisting patients to become aware of symptomatic changes in mood, cognition and behavior; to categorise these symptoms and processes with their clinicians and to use this information and skill set to develop coping strategies for prodromal symptoms (e.g. strategic and responsive lifestyle alterations, behavioral modification or seeking assistance) (Lam et al., 1999). Research has demonstrated that patients with bipolar disorders can effectively recognise and report prodromal symptoms of a behavioral, mood and cognitive nature (Lam et al., 2001; Mantere et al., 2008) and can distinguish between both elevated and depressed symptoms (Jackson et al., 2003) – findings which lend weight to the appropriateness of this approach in treating bipolar patients in active and remission phases.
The Early Symptom Monitoring Inventory provides a simple, low time investment method for patients to report daily mood states (both high and low, and with a measure of severity) and critical preventative behaviors (sleep, exercise, medication adherence and existence of life stress). It is tailored to be a general inventory, and is therefore able to be usilied in any of the relevant therapies noted above where early monitoring of prodromal symptoms is prescribed by the treating clinician.
Why complete the Early Symptom Monitoring Inventory (ESMI)?
Early symptom monitoring and management is an important part of many collaborative psychological treatments for bipolar disorders. It has been shown to be beneficial in preventing relapse.
Bipolar symptoms fluctuate, and early recognition of their direction, their severity, their cycle and their relationship to other factors like medication levels and life stress, is essential in accurately diagnosing and successfully treating the disorder.
Regularly completing the ESMI lets you monitor your symptoms and warning signs over time. The ESMI collates daily information of your moods, medication, sleep patterns and stressful events, and produces a chart which you and your clinician can use to monitor whether you are recovering or whether you are experiencing a worsening of symptoms which require early action to reduce the chance of relapse. Attempting to remember this information over time can be difficult, and especially when you are unwell. Understanding this information can help you see important relationships and patterns that could otherwise be undetected.
How do I complete the ESMI?
The ESMI is conveniently contains a whole month on one sheet. You can print it out and complete by hand, or complete the file electronically.
After entering your name and the relevant month and year, complete the form each day as follows:
• Mood: At the same time each day tick the column for that day twice – one for the highest elevation of mood, and one for the lowest dip in mood for that day.
o If you experienced a particular symptom you believe important to record in detail, additionally enter the date and details of that symptom in the Detailed Notes sheet.
• Sleep: At the same time each day enter the length of time you slept in that day in hours.
• Medication:
o Medication Name: Enter the name of each of your medications at each line in the document provided.
o Daily Medication Dose Taken: At the same time each day enter in the column for that day the dose in mg of the medication you have used.
• Stressful Life Event: If you have experienced a stressful life event in a particular day, tick the box for that day, and then enter the date and details of that event in the Detailed Notes sheet.
• Exercise: At the same time each day tick the column for that day if you have exercised in a way that you believe reflects the exercise discussed in your treatment sessions.
What should I do if I notice an increase in symptom severity?
To ensure the best chances of avoiding relapse, it is important that you contact people in your designated support network and your psychologist if you notice any increase in symptom severity.
References
Castle, D., Berk, M., Berk, L., Lauder, S., Chamberlain, J. & Gilbert, M. (2007).
Pilot of group intervention for bipolar disorder. International Journal of Psychiatry in
Clinical Practice, 11 (4), 279-284.
Colom, F., Vieta, E., Reinares, M., Marinez-Aran, Torrent, C., Goikolea, J.M. &
Frank, E., Swartz, H.A. & Kupfer, D.J. (1999). Interpersonal and Social Rhythm
therapy: managing the chaos of bipolar disorder. Biological Psychiatry, 48 (6), 593-60
Gasto, C. (2003). Psychoeducation efficacy in bipolar disorders: Beyond compliance
enhancement. Journal of Clinical Psychiatry, 64 (9), 1101- 110
Gitlin, M.J., Swendsen, J., Heller, T.L. & Hammen, C. (1995). Relapse and
impairment in bipolar disorder. American Journal of Psychiatry. 152, 1635-1640.
Hill, R., Hardy, P. & Shepherd, G. (1996). Perspectives on manic depression: A
survey of the manic depression fellowship. London: The Sainsbury Centre for Mental
Health.
Jackson, A., Cavanagh, J. & Scott, J. (2003). A systematic review of manic and
depressive prodromes. Journal of Affective Disorders, 74, 209-217.
Joyce, P.R. (1985). Illness behaviour and rehospitalisation in bipolar affective
disorder. Psychological Medicine, 15, 521-525.
Lam, D.H., Jones, S.H., Hayward, P. & Bright, J.A. (1999). Cognitive therapy
for bipolar disorder: A therapist's guide to concepts, methods & practice. John Wiley & Sons, Ltd. Chichester.
Lam, D.H., Bright, J., Jones, S., Hayward, P., Schuck, N., Chisholm, D. & Sham,
P. (2000). Cognitive therapy for bipolar illness – A pilot study of relapse prevention.
Cognitive Therapy and Research, 24 (5), 503-520.
Lam, D.H., Watkins, E.R., Hayward, P., Bright, J., Wright, K., Kerr, N. et al.
(2003). A randomized controlled study of cognitive therapy for relapse prevention for
bipolar affective disorder. Archives of General Psychiatry, 60, 145- 15.
Lam, D.H., Hayward, P., Watkins, E.R., Wright, B.A., & Sham, P. (2005).
Relapse prevention in patients with bipolar disorder: Cognitive therapy outcome after 2 years. American Journal of Psychiatry, 162 (2), 324-329.
Lish, J.D., Dime-Meenan, S., Whybrow, P.C., Price, R.A., Hirshfield, R.M.
(1994). Bipolar Depression: The real challenge. European Neuropsychopharmacology, 14, S83-S88.
Mantere, O., Suominen, K., Valtonen, H.M., Arvilommi, P. & Isometsa, E.
(2008). Only half of bipolar I & II patients report prodromal symptoms. Journal of Affective Disorders, 111 (2), 366-371.
Molnar, G., Feeney, G. & Fava, G. (1988). Duration and symptoms and bipolar prodromes. American Journal of Psychiatry, 145, 1576- 1577.
Morriss, R., Marshall, M. & Harris, A. (2002). Bipolar affective disorder – left out in the cold. British Medical Journal, 324(7329), 61-62.
Perry, A., Tarrier, N., Morriss, R., McCarthy, E., & Limb, K. (1999). Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. British Medical Journal, 318, 149-153
Scott, J., Stanton, B., Garland, A., & Moorhead, S. (2001). A pilot study of cognitive therapy in bipolar disorder. Psychological Medicine, 31, 459-467.
Simoneau, T.L., Miklowitz, D.J., Richards, J.A., Saleem, R. & George, E.L. (1999). Bipolar disorder and family communication: Effects of a psychoeducational treatment program. Journal of Abnormal Psychology, 108 (4), 588-597.
Monday, October 15, 2012
Social Media Election
Created by http://open-site.org">

Created by http://open-site.org">
http://www.thepresentparticiple.blogspot.com
Wednesday, October 10, 2012
Resilience in Children - Moving from Deficit to Strength-Based Models. - Luke Fullagar
Sunday, October 7, 2012
Synthesis, Play, Dreaming.
Wednesday, September 26, 2012
Evidence-Based Treatment of Post-Traumatic Stress Disorder
Evidence-Based Treatment of Post-Traumatic Stress Disorder
Luke Fullagar
RMIT University
This paper outlines the evidence base for the treatment of post-traumatic stress disorder (PTSD) in adults. Due to its Australian-context, this paper primarily relies on the meta-analysis completed by the Australian Centre for Posttraumatic Mental Health (ACPMH ) in 2007 (ACPMH, 2007), which includes and transcends the prior seminal systematic meta-analysis undertaken by United Kingdom National Institute for Clinical Excellence (NICE) in 2005 (NICE, 2005). Given word restrictions, for brevity, study references in this paper will generally refer to additional studies included in the expanded evidence-base reviewed by the ACPMH, and should be taken as extending rather than ignoring the NICE evidence base (as is the spirit of the ACPMH report).
Currently, the strongest-evidence base for psychological treatment of adults with PTSD is in respect of two trauma-focussed interventions: trauma-focussed cognitive behavioural therapy (TF-CBT) and eye movement desensitization (EMDR) and reprocessing treatment together with in vivo exposure therapy (ACPMH, 2007). Over 30 controlled studies support these broad conclusions and demonstrate effectiveness in both PTSD symptoms and with comorbid depression and anxiety (ACPMH, 2007). The following expands on this evidence, and concludes with a comparison of these treatments, and their recommended application in clinical settings.
Randomised controlled trials comparing TF-CBT in a range of contexts (e.g. earthquake victims, partner abuse), have demonstrated consistent, statistically-significant clinical superiority to waitlist conditions in reducing PTSD symptom severity and post-treatment diagnosis (both self-reported and clinician-rated) (ACPMH, 2007; Ehlers et al., 2005; Kubany et al., 2004; Basoglu et al., 2005; Lindauer et al., 2005; McDonagh et al., 2005; Rothbaum et al., 2005). Moreover, two studies have demonstrated statistically-significant improvements in functioning in people receiving FT-CBT when compared with waitlist-conditions (ACPMH, 2007; Ehlers et al., 2005; Basoglu et al., 2005). While the NICE study found significant evidence favouring FT-CBT over waitlist-conditions in reducing anxiety-related symptoms, subsequent studies reviewed by the ACPMH found a variant, and overall lesser standard of evidence (ACPMH, 2007; McDonagh, 2005; Ehlers, 2005). The NICE study found limited evidence for clinical superiority of FT-CBT over waitlist conditions for depression symptoms (NICE, 2005), and while observing a range of studies with very low or no statistically-significant reductions in depressive-symptoms, the ACPMH study noted two studies which demonstrated this relationship in populations which were predominantly woman aged in their late 30s to 40s (ACPMH, 2007; Kubany 2004; Ehlers, 2005). Currently, evidence is unclear on the efficacy or clinical importance of FT-CBT in increasing self-reported quality of life (ACPMH, 2007; McDonagh, 2005).
Similarly, there is limited, relevant evidence supporting EDMR over waitlist-conditions in reducing PTSD symptom severity and post-treatment diagnosis (both self-reported and clinician-rated), depressive symptoms, anxiety symptoms and in increasing self-reported quality of life (NICE, 2005).
When comparing these treatments, both the NICE and ACPMH meta-analyses revealed inconclusive evidence to determine whether TF-CBT and EDMR differ in clinical importance on reducing PTSD symptom severity, post-treatment diagnosis (both self-reported and clinician-rated), clinician-rated symptom severity at 3 month follow up, anxiety symptoms at treatment conclusion and at 2-5 month follow-up, and in increasing self-reported quality of life (ACPMH, 2007; NICE, 2005). Evidence also suggests that there is unlikely to be a clinically important difference between these treatments in respect of self-reported PSTD symptoms at 3-month follow-up, self-reported depression symptoms at 2-5 month follow-up, and limited evidence favouring EDMR over TF-CBT in reducing self-reported depression symptoms at treatment cessation (ACPMH, 2007; NICE, 2005).
However, despite these statistical results in meta-analyses, a close inspection of the cases making up these analyses reveals qualitative differences in follow-up outcomes (ACPMH, 2007). There is support for opposing views: two studies demonstrate exposure's superiority over EDMR (which demonstrated some return to baseline at follow-up) (Devilly & Spence, 1999; Taylor, 2003) and another with regard to depression and end-state functioning at follow-up (Rothbaum, 2005); while in the converse Ironson (2002) and Lee (2002) demonstrate EDMR's superiority at follow-up. The ACPMH (2007) argue that alterations to contemporary EDMR which include in vivo exposure and CBT techniques such as cognitive interweaving, future templating, create confounds in this comparison, and that there is therefore a case for treating contemporary EDMR as a variant of TF-CBT (ACPMH, 2007). This view is supported by evidence suggesting that the aforementioned elements of contemporary EDMR potentially contribute more than the eye-movements themselves (Foley & spates, 1995; Renfrey & Spates, 1994), and critically, the cognitive restructuring and exposure components.
While some evidence exists suggesting that cognitive restructuring and exposure components are efficacious on their own and demonstrate no improved outcomes when combined (Bryant, 2005; Marks, 1998), the lack of independence between these two treatment variables confounds the current evidence, and accordingly, no conclusive position is yet available on this point (ACPMH, 2007). On this point, it is also important to note that other treatments such as psychoeducation, anxiety management and stress-inoculation training – which have demonstrated better than wait-list effectiveness yet lower than trauma-focussed treatment effectiveness in reducing post-treatment diagnosis, on follow-up and in treating comorbidities – are all included as elements in the more efficacious trauma-focussed treatments described herein (ACPMH, 2007).
No current evidence base exists for recommending a number of treatment sessions, and studies included in meta-analyses have ranged from single sessions to treatment protocols of 4-14 sessions (ACPMH, 2007).
No current evidence exists demonstrating any superiority of pharmacotherapy over trauma-focussed psychotherapeutic interventions on any of the abovementioned measures, and importantly, on dealing with depression comorbidity (NICE, 2005). Accordingly, it is recommended by NICE and ACPMH that pharmacotherapy not form a routine non-selective first-line treatment for traumatised adults in preference to trauma-focussed psychotherapy (ACPMH, 2007). However, on the basis of a Cochrane Review (Stein et al, 2006), which demonstrates that the greatest number of trials demonstrating efficacy were in respect of SSRIs, ACPMH recommends that where medication is prescribed in the treatment of PTSD in traumatised adults, SSRI antidepressants should be the first-choice.
References
ACPMH (Australian Centre for Posttraumatic Mental Health). (2007). Australian Guidelines for Treatment of Adults with Acute Stress Disorder and Posttraumatic Stress Disorder. Melbourne: Australian Centre for Posttraumatic Mental Health.
Basoglu, M., Salcioglu, E., Livanou, M., Kalender, D., & Acar, G. (2005). Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: A randomized waiting list controlled trial. Journal of Traumatic Stress, 18(1), 1–11.
Bryant, R. A., Moulds, M. L., Guthrie, R. M., & Nixon, R. D. V. (2005). The additive benefit of hypnosis and cognitive-behavioral therapy in treating acute stress disorder. Journal of Consulting and Clinical Psychology, 73(2), 334–340.
Devilly, G. J., & Spence, S. H. (1999). The relative efficacy and treatment distress of EMDR and a cognitive-behavior trauma treatment protocol in the amelioration of posttraumatic stress disorder. Journal of Anxiety Disorders, 13(1–2), 131–157.
Ehlers, A., Clark, D. M., Hackmann, A., McManus, F., & Fennell, M. (2005). Cognitive therapy for post-traumatic stress disorder: development and evaluation. Behaviour Research and Therapy, 43(4), 413–431.
Foley, T., & Spates, C. R. (1995). Eye movement desensitiation of public-speaking anxiety: A partial dismantling. Journal of Behavior Therapy and Experimental Psychiatry, 26, 321–329.
Ironson, G., Freund, B., Strauss, J. L., & Williams, J. (2002). Comparison of two treatments for traumatic stress: A community-based study of EMDR and prolonged exposure. Journal of Clinical Psychology, 58(1), 113–128.
Kubany, E. S., Hill, E. E., Owens, J. A., Iannce-Spencer, C., McCaig, M. A., Tremayne, K. J., & Williams, P. L. (2004). Cognitive Trauma Therapy for Battered Women With PTSD (CTT-BW). Journal of Consulting and Clinical Psychology, 72(1), 3–18.
Lee, C., Gavriel, H., Drummond, P., Richards, J., & Greenwald, R. (2002). Treatment of PTSD: Stress inoculation training with prolonged exposure compared to EMDR. Journal of Clinical Psychology, 58(9), 1071–1089.
Lindauer, R. J. L., Gersons, B. P. R., van Meijel, E. P. M., Blom, K., Carlier, I. V. E., Vrijlandt, I., & Olff, M. (2005). Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: Randomized clinical trial. Journal of Traumatic Stress, 18(3), 205–212.
Marks, I., Lovell, K., Noshirvani, H., Livanou, M., & Thrasher, S. (1998). Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: A controlled study. Archives of General Psychiatry, 55(4), 317–325.
McDonagh, A., Friedman, M., McHugo, G., Ford, J., Sengupta, A., Mueser, K., Demment, C. C., Fournier, D., Schnurr, P. P., & Descamps, M. (2005). Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. Journal of Consulting and Clinical Psychology, 73(3), 515–524.
NICE (National Institute for Clinical Excellence) (2005). The Management of PTSD in Adults and Children in Primary and Secondary Care (Vol. 26). Wilshire: Cromwell Press Ltd.
Renfrey, G., & Spates, C. G. (1994). Eye movement desinsitization: A partial dismantling study. Journal of Behavior Therapy and Experimental Psychiatry, 25, 231–239.
Rothbaum, B. O., Astin, M. C., & Marsteller, F. (2005). Prolonged exposure versus eye movement desensitization and reprocessing (EMDR) for PTSD rape victims. Journal of Traumatic Stress, 18(6), 607–616.
Stein, D. J., Ipser, J. C., & Seedat, S. (2006). Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews(1).
Taylor, S., Thordarson, D. S., Maxfield, L., Fedoroff, I. C., Lovell, K., & Ogrodniczuk, J. (2003). Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. Journal of Consulting and Clinical Psychology, 71(2), 330–338.